Header cover image

Norwegian (OSEAX) Pharma Industry Analysis

UpdatedDec 24, 2025
DataAggregated Company Financials
Companies5
  • 7D0.6%
  • 3M5.0%
  • 1Y0.8%
  • YTD-5.4%

The Pharma industry is up 2.6% in the last week, with Photocure up 6.6%. During this same period, the Navamedic underperformed, falling 5.4%. Overall in the last year, the industry is flat. Earnings are forecast to grow by 131% annually.

Industry Valuation and Performance

Has the Norwegian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 24 Dec 2025NOK 3.6bNOK 1.6b-NOK 67,438,434.00436.7x-54x2.3x
Fri, 21 Nov 2025NOK 3.2bNOK 1.6b-NOK 79,791,434.00375.7x-40.3x2.1x
Sun, 19 Oct 2025NOK 3.2bNOK 1.5b-NOK 83,687,434.0012.6x-38.5x2.1x
Tue, 16 Sep 2025NOK 3.4bNOK 1.5b-NOK 87,981,434.0013.8x-38.8x2.2x
Thu, 14 Aug 2025NOK 3.6bNOK 1.5b-NOK 99,333,434.0014.2x-35.7x2.3x
Sat, 12 Jul 2025NOK 3.3bNOK 1.5b-NOK 91,864,434.00351.8x-36.4x2.2x
Mon, 09 Jun 2025NOK 3.2bNOK 1.5b-NOK 115,163,434.00327.4x-27.8x2.1x
Wed, 07 May 2025NOK 3.4bNOK 1.5b-NOK 121,381,000.0014.8x-28x2.2x
Fri, 04 Apr 2025NOK 3.1bNOK 1.5b-NOK 131,427,000.00145.3x-23.5x2.1x
Sun, 02 Mar 2025NOK 3.1bNOK 1.5b-NOK 13,494,743.00152.3x-229x2.1x
Tue, 28 Jan 2025NOK 3.2bNOK 1.5bNOK 22.4m21.5x142.9x2.2x
Thu, 26 Dec 2024NOK 3.3bNOK 1.5bNOK 22.4m22.9x145.7x2.2x
Sat, 23 Nov 2024NOK 2.9bNOK 1.5bNOK 34.6m23.3x83.3x1.9x
Mon, 21 Oct 2024NOK 3.1bNOK 1.5bNOK 45.2m22.1x69.7x2.1x
Wed, 18 Sep 2024NOK 3.2bNOK 1.5bNOK 45.2m20.9x70.4x2.1x
Fri, 16 Aug 2024NOK 2.8bNOK 1.5bNOK 57.7m59.5x49.1x1.9x
Sun, 14 Jul 2024NOK 3.1bNOK 1.5bNOK 49.7m172.6x62.6x2.1x
Tue, 11 Jun 2024NOK 3.5bNOK 1.5bNOK 7.6m192.2x461.3x2.4x
Thu, 09 May 2024NOK 3.2bNOK 1.5bNOK 3.0m3003.8x1074.7x2.2x
Sat, 06 Apr 2024NOK 3.2bNOK 1.5bNOK 7.6m163.6x421.1x2.2x
Mon, 04 Mar 2024NOK 3.2bNOK 1.5bNOK 33.1m168.3x97.4x2.2x
Wed, 31 Jan 2024NOK 3.5bNOK 1.4bNOK 18.6m25.6x190.4x2.5x
Fri, 29 Dec 2023NOK 3.5bNOK 1.4bNOK 18.6m24.5x187.8x2.5x
Sun, 26 Nov 2023NOK 3.0bNOK 1.4bNOK 18.6m23.9x161.9x2.1x
Tue, 24 Oct 2023NOK 3.2bNOK 1.3b-NOK 38,433,125.0053x-82.6x2.4x
Thu, 21 Sep 2023NOK 3.4bNOK 1.3b-NOK 53,836,125.0053.5x-63.8x2.6x
Sat, 19 Aug 2023NOK 2.8bNOK 1.3b-NOK 60,691,125.0080x-45.7x2.1x
Mon, 17 Jul 2023NOK 3.0bNOK 1.2b-NOK 60,357,125.0073x-49.6x2.4x
Wed, 14 Jun 2023NOK 3.3bNOK 1.2b-NOK 104,503,000.0080x-31.2x2.6x
Fri, 12 May 2023NOK 3.2bNOK 1.2b-NOK 118,389,000.0081.8x-27.1x2.7x
Sun, 09 Apr 2023NOK 3.2bNOK 1.1b-NOK 140,813,000.0023.9x-22.5x2.9x
Tue, 07 Mar 2023NOK 3.7bNOK 1.1b-NOK 140,813,000.0023.1x-26.5x3.4x
Thu, 02 Feb 2023NOK 4.6bNOK 1.0b-NOK 148,546,289.0049x-30.8x4.5x
Sat, 31 Dec 2022NOK 4.5bNOK 1.0b-NOK 148,546,289.0049x-30x4.4x
Price to Earnings Ratio

-30x


Total Market Cap: NOK 4.5bTotal Earnings: -NOK 148,546,289.00Total Revenue: NOK 1.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Pharma Industry Price to Earnings3Y Average 40.9x202320242025
Current Industry PE
  • Investors are relatively neutral on the Norwegian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 2.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare industry?

NO Market1.89%
Healthcare5.02%
Pharma0.60%
Pharma0.60%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PHO PhotocureNOK 68.604.7%
+NOK 82.5m
7.4%PE861.8x
SOFTX SoftOx SolutionsNOK 0.0616.3%
+NOK 8.6m
238.9%PS10.7x

Latest News